Sriharsha Tella to Aged, 80 and over
This is a "connection" page, showing publications Sriharsha Tella has written about Aged, 80 and over.
Connection Strength
0.381
-
Association Between Hospital Volume, Therapy Types, and Overall Survival in Stage III and IV Cutaneous Malignant Melanoma. J Natl Compr Canc Netw. 2019 11 01; 17(11):1334-1342.
Score: 0.091
-
Predictors of Survival in Adrenocortical Carcinoma: An Analysis From the National Cancer Database. J Clin Endocrinol Metab. 2018 09 01; 103(9):3566-3573.
Score: 0.084
-
Incidence, racial disparities and survival outcomes of mast cell malignancies: analysis from a national database. Leuk Lymphoma. 2018 09; 59(9):2254-2257.
Score: 0.081
-
Association Between Treatment Facility Volume, Therapy Types, and Overall Survival in Patients With Stage IIIA Non-Small Cell Lung Cancer. J Natl Compr Canc Netw. 2019 03 01; 17(3):229-236.
Score: 0.022
-
Association between treatment facility volume, therapy types and overall survival in patients with intrahepatic cholangiocarcinoma. HPB (Oxford). 2019 03; 21(3):379-386.
Score: 0.021
-
T cell/histiocyte-rich large B cell lymphoma: incidence, demographic disparities, and long-term outcomes. Br J Haematol. 2019 04; 185(1):140-142.
Score: 0.021
-
Natural Killer/T-cell Neoplasms: Analysis of Incidence, Patient Characteristics, and Survival Outcomes in the United States. Clin Lymphoma Myeloma Leuk. 2018 07; 18(7):475-479.
Score: 0.021
-
A prognostic scoring model for survival after locoregional therapy in de novo stage IV breast cancer. Breast Cancer Res Treat. 2018 Aug; 170(3):677-685.
Score: 0.021
-
Histiocytic sarcoma: a population-based analysis of incidence, demographic disparities, and long-term outcomes. Blood. 2018 01 11; 131(2):265-268.
Score: 0.020